Elise C. Kohn

Dose-intense taxol: high response rate in patients with platinum-resistant recurrent ovarian cancer.

F. Ognibene, S. Steinberg, E. Kohn, 1994, Journal of the National Cancer Institute.

Tumor angiogenesis in advanced stage ovarian carcinoma.

S. Steinberg, E. Kohn, M. Merino, 1995, The American journal of pathology.

High-dose carboplatin and recombinant granulocyte-macrophage colony-stimulating factor in advanced-stage recurrent ovarian cancer.

E. Kohn, R. Ozols, J. Janik, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Incapacitating autonomic neuropathy precipitated by taxol.

E. Kohn, C. Link, E. Reed, 1993, Gynecologic oncology.

Combination therapy: intermittent sorafenib with bevacizumab yields activity and decreased toxicity

E. Kohn, L. Minasian, N. Azad, 2010, British Journal of Cancer.